Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer?

@article{Boffa2010ShouldT7,
  title={Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer?},
  author={Daniel J. Boffa and Frank C. Detterbeck and Erica J. Smith and Ram{\'o}n Rami-Porta and John Powers Crowley and Daniel Zelterman and Lynn T Tanoue and Anthony W Kim and Peter Goldstraw},
  journal={Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer},
  year={2010},
  volume={5 11},
  pages={
          1779-83
        }
}
INTRODUCTION Approximately 10 to 15% of non-small cell lung cancer patients will be assigned a stage classification according to the 7th edition of TNM that differs from that assigned by the 6th edition (the "stage shifters"). This apparent upstaging or downstaging of tumors may affect patient management, as many clinicians formulate stage-based management strategies. However, the staging system revision was not designed to evaluate treatment, and attempts to make parallel adjustments in… CONTINUE READING
1
Twitter Mention

Citations

Publications citing this paper.
SHOWING 1-8 OF 8 CITATIONS

A pooled exploratory analysis of the effect of tumor size and KRAS mutations on survival benefit from adjuvant platinum-based chemotherapy in node-negative non-small cell lung cancer.

  • Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • 2012
VIEW 3 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED